Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

fampridine

EU orphan designation number: EU/3/07/458   
Active ingredient: fampridine
Indication: Treatment of Guillain-Barré syndrome
Sponsor: Dr Ulrich Granzer
Granzer Regulatory Consulting & Services, Zielstattstraße 44, D-81379 München, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/07/2007 Centralised Orphan - Designation EMEA/OD/101/06 (2007)3433 of 10/07/2007